![discount label](https://static.cymitquimica.com/public/img/discount.png)
Product Information
- 2-Butenamide
- 2-cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-
- 2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-butenamide
- 2-Cyano-3-hydroxy-N-(4-trifluoromethylphenyl)crotonamide
- 2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]but-2-enamide
- (EZ)-Teriflunomide
- 2-Cyano-3-hydroxy-N-(4'-trifluoromethylphenyl)-crotone amide
- (2Z)-2-(hydroxy{[4-(trifluoromethyl)phenyl]amino}methylidene)-3-oxobutanenitrile
- (Z)-2-Cyano-alpha'alpha'alpha-trifluoro-3-hydroxy-p-crotonotoluidide
- 2-Butenamide, 2-cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)-
- See more synonyms
- 2-Cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)-2-butenamide
- A 771726
- A771726
- Active metabolite of leflunomide
- Flucyamide
- Hmr 1726
- Malononitrilamide
- N-(4-Trifluoromethylphenyl)-2-cyano-2-hydroxycrotonamide
- Su 20
- Teriflunomide
- Teriflunomide [INN]
- Unii-1C058Ikg3B
Impurity Leflunomide USP Related Compound B
Applications rac A77 1726 is the active metabolite of Leflunomide, a potent disease-modifying antirheumatic drug used in the treatment of rheumatoid arthritis. LEF-M interferes with dendritic cell function. The second Phase III study evaluating the efficacy of Genzyme’s teriflunomide therapy against relapsing forms of multiple sclerosis found the once-daily oral drug to be no less effective than injectable interferon beta 1a (Rebif®). Leflunomide USP Related Compound B.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Kirsch, B.M., et al.: Arthritis Research and Therapy, 7, 3, R694, (2005)
Chemical properties
Technical inquiry about: TR-A771720 A77 1726 (E/Z) Mixture
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.